|
Key Dates:
Key Dates:
Friday, November 4 , 2011
Biological Therapeutics and Cancer: Basic Science, Development, Delivery, and Clinical Evaluations
An international symposium hosted by the CIHR Biological Therapeutics Training Program. Please click here for more information.
Biotherapeutics 2011 Summer Student Poster day, Thursday August 11, 11:00am to 1:00pm
PB 850
Congratulations!
Dr. Irina Brokhman awarded Hugh Sellers Postdoctoral Fellowship one year award from The Banting & Best Diabetes Centre(BBDC)
(Primary Supervisor: Dr. Derek van der Kooy
, Secondary Supervisor: Dr. Shelley Boyd)
Lillian Doss, a Trainee in he program has started an internship at the Millenium Research Group.
Ingrid Xuan, an M.Sc. student in the program is engaged in a 2011 summer internship at Patheon Inc. in Toronto. The position is "Technologist I" in the pharmaceutics and process technology department. She will be responsible for performing formulation, scale up and other manufacturing related assignments in a high potency drug development project.
Dr. Shervin Gholizadeh, Trainee, for being awarded a prestigious Vanier Graduate Scholarship.
Matthew Durk, Trainee, for being awarded an Internship with NoAb BioDiscoveries Inc.
Diane Cockburn, Trainee, for being awarded an Internship with GlaxoSmithKleine
Dr. Paul Spagnuolo awarded International Leukemia Fellowship
|
Tumor-penetrating transport of cancer drugs is activated by the peptide iRGD (multicolored ring), which binds to integrin receptors (blue and yellow) in tumor blood vessels, and is subsequently cleaved. The cleaved peptide then binds to neuropilin-1 receptors (purple), activating a transport system that carries coadministered drugs, such as antibodies (green), deeper into tumor tissue.
Image: Peter Allen/University of California, Santa Barbara
Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs, Kazuki N. Sugahara, et al.
Science 328, 1031 (2010);
|
|
